Scarica l'app Stockscreener
183.87
0.40%
1.015
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché AZN Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$182.85
Aprire:
$183.79
Volume 24 ore:
1.09M
Relative Volume:
0.53
Capitalizzazione di mercato:
$284.81B
Reddito:
$60.48B
Utile/perdita netta:
$10.40B
Rapporto P/E:
55.22
EPS:
3.3297
Flusso di cassa netto:
$8.05B
1 W Prestazione:
+0.07%
1M Prestazione:
-10.02%
6M Prestazione:
+106.07%
1 anno Prestazione:
+171.70%
Intervallo 1D:
$183.25
$185.81
Intervallo di 1 settimana:
$180.00
$185.81
Portata 52W:
$66.16
$212.71
Astrazeneca Plc Stock (AZN) Company Profile
Nome
Astrazeneca Plc
Settore
Industria
Telefono
-
Indirizzo
-
Compare AZN vs LLY, JNJ, ABBV, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AZN
Astrazeneca Plc
|
183.65 | 283.57B | 60.48B | 10.40B | 8.05B | 3.3297 |
LLY
Lilly Eli Co
|
975.33 | 845.77B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
220.82 | 532.77B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
202.75 | 356.49B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
145.53 | 278.64B | 54.66B | 13.58B | 16.05B | 7.0171 |
Astrazeneca Plc Stock (AZN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | Citigroup | Buy |
| 2025-10-27 | Ripresa | Jefferies | Buy |
| 2025-10-16 | Downgrade | Deutsche Bank | Hold → Sell |
| 2025-04-15 | Iniziato | Exane BNP Paribas | Outperform |
| 2025-02-13 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-12 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-20 | Aggiornamento | UBS | Sell → Neutral |
| 2024-11-06 | Aggiornamento | Deutsche Bank | Sell → Hold |
| 2024-09-13 | Downgrade | Deutsche Bank | Hold → Sell |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-04-16 | Aggiornamento | Deutsche Bank | Sell → Hold |
| 2024-02-08 | Downgrade | Deutsche Bank | Hold → Sell |
| 2024-01-23 | Iniziato | Morgan Stanley | Overweight |
| 2024-01-16 | Ripresa | UBS | Sell |
| 2024-01-03 | Downgrade | Jefferies | Buy → Hold |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-09-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Buy |
| 2023-07-12 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-05 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-04-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-01-05 | Iniziato | BMO Capital Markets | Outperform |
| 2022-09-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-29 | Aggiornamento | Argus | Hold → Buy |
| 2022-06-14 | Downgrade | UBS | Buy → Neutral |
| 2022-02-11 | Aggiornamento | DZ Bank | Sell → Hold |
| 2021-12-07 | Downgrade | Jefferies | Buy → Hold |
| 2021-08-12 | Ripresa | JP Morgan | Overweight |
| 2021-04-12 | Downgrade | Argus | Buy → Hold |
| 2021-03-16 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-25 | Aggiornamento | UBS | Neutral → Buy |
| 2021-01-15 | Iniziato | Deutsche Bank | Buy |
| 2020-12-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-30 | Aggiornamento | UBS | Sell → Neutral |
| 2020-11-11 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2020-09-29 | Iniziato | Berenberg | Buy |
| 2019-11-22 | Iniziato | SVB Leerink | Outperform |
| 2019-10-25 | Aggiornamento | Liberum | Hold → Buy |
| 2019-04-02 | Downgrade | UBS | Neutral → Sell |
| 2019-02-05 | Iniziato | Exane BNP Paribas | Outperform |
| 2019-01-25 | Aggiornamento | Shore Capital | Hold → Buy |
| 2018-12-11 | Ripresa | Jefferies | Hold |
| 2018-10-09 | Iniziato | Guggenheim | Buy |
| 2018-08-16 | Downgrade | Jefferies | Buy → Hold |
| 2018-03-19 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-02-06 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-05 | Reiterato | Bernstein | Outperform |
| 2018-01-18 | Reiterato | Leerink Partners | Mkt Perform |
| 2017-12-29 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2017-10-16 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2017-09-25 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2017-09-22 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
Mostra tutto
Astrazeneca Plc Borsa (AZN) Ultime notizie
AstraZeneca plc stock (GB0009895292): Beats Q1 Estimates, Analysts Raise Targets - AD HOC NEWS
AstraZeneca stock (US6549022043): Beats Q1 Estimates, Analysts Raise Targets - AD HOC NEWS
What next for AstraZeneca shares, after another cracking quarter? - MSN
AstraZeneca PLC stock (US6549022043): Strong 2025 results and pipeline momentum - AD HOC NEWS
AstraZeneca plc stock (GB0009895292): Pharma giant eyes growth amid pipeline progress and pricing pr - AD HOC NEWS
AstraZeneca wins FDA AdCom backing for Truqap in prostate cancer - MSN
First City Capital Management, Inc.'s AstraZeneca PLC(AZN) Holding History - GuruFocus
AstraZeneca (AZN) officer Sharma Mani granted additional Ordinary Shares - Stock Titan
Darren Sissons' Past Picks: AstraZeneca, Canadian Pacific Kansas City & Linde Plc - BNN Bloomberg
AstraZeneca plc Stock (GB0009895292): Strong Quarterly Results and Improved Outlook Support Shares - AD HOC NEWS
AstraZeneca PLC stock (US6549022043): Strong quarterly results and improved guidance lift AZN shares - AD HOC NEWS
Fund Update: 25,553,763 ASTRAZENECA (AZN) shares added to Legal & General Group Plc portfolio - Quiver Quantitative
AstraZeneca Advances Respiratory And Oncology Portfolio Within FTSE 350 - Kalkine Media
AstraZeneca stock price forecast: GBX13,000 support holds as AZN edges lower - Traders Union
Alteogen posts weaker Q1 as Korea tech deals lag last year’s AstraZeneca windfallCHOSUNBIZ - Chosunbiz
AstraZeneca Reps Fight To Keep Opt-Ins In Pay Bias Suit - Law360
PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
AstraZeneca slides Thursday, underperforms market - MarketWatch
AstraZeneca and OMP Demonstrate Planning at the Speed of Change at Gartner Supply Chain Symposium/Xpo(TM) 2026 - marketscreener.com
Jazz, AstraZeneca, Astellas: Foreign Healthcare's strongest Quant picks (JAZZ:NASDAQ) - Seeking Alpha
Eli Lilly To Invest $4.5 Billion More In Indiana Manufacturing SitesAstraZeneca (NYSE:AZN), Johnson & - Benzinga
AstraZeneca PLC (NYSE:AZN) Q1 2026 Earnings Call Transcript - Insider Monkey
Buying pressure lifts AstraZeneca stock higher in today's trading - Traders Union
AstraZeneca stock edges higher as revenue surpasses forecasts at $15.29 billion - Traders Union
MSN Money - MSN
AstraZeneca Earnings Call: Oncology Strength, Pipeline Bets - TipRanks
AstraZeneca Shareholder Notice - TMX Newsfile
AstraZeneca Advances Early Liver-Function Trial That Could Shape Dosing for Future AZN Drugs - TipRanks
AZN Stock Quote Price and Forecast - CNN
AstraZeneca PLC Share PriceAZN, RNS News, Articles, Quotes, & Charts (LON:AZN) - Proactive Investors
Strong Results and Improved Guidance Lifted AstraZeneca PLC (AZN) - Yahoo Finance
AstraZeneca PLC (AZN) Stock Analysis: Unpacking A 21% Potential Upside Opportunity - DirectorsTalk Interviews
AstraZeneca stock drops 2.88% as shares remain below recent trading averages - Traders Union
Global pharma companies that have publicly announced Trump drug pricing agreements - Reuters
ASTRAZENECA : Bernstein reaffirms its Buy rating - marketscreener.com
Mixed FDA Votes On Truqap And Camizestrant Refocus AstraZeneca Oncology Risk - Yahoo Finance
Is AstraZeneca PLC (AZN) A Good Stock To Buy Now? - Insider Monkey
AstraZeneca invests £300 million in UK drug development sites - marketscreener.com
FTSE 100 Today Focus on BP plc (LSE:BP), Shell plc (LSE:SHEL) and AstraZeneca plc (LSE:AZN) - Kalkine Media
FIGURE 8 INVESTMENT STRATEGIES LLC's AstraZeneca PLC(AZN) Holding History - GuruFocus
Astrazeneca Plc $AZN Shares Sold by D.A. Davidson & CO. - MarketBeat
Alhambra Investment Management LLC's AstraZeneca PLC(AZN) Holding History - GuruFocus
AstraZeneca | Pharmaceuticals, Vaccines, & Facts | Britannica Money - Britannica
Transamerica MSCI EAFE Index VP's AstraZeneca PLC(LSE:AZN) Holding History - GuruFocus
Fidelity Sustainable International Equity Fund's AstraZeneca PLC(LSE:AZN) Holding History - GuruFocus
UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weigh - marketscreener.com
AstraZeneca slides Friday, underperforms market - MarketWatch
UK's FTSE 100 Closes Lower; NatWest, AstraZeneca Shares Down - marketscreener.com
AstraZeneca updates voting rights and admits new shares to London Stock Exchange - Investing.com
Employee share plans add 14,807 AstraZeneca (AZN) shares to LSE - Stock Titan
FDA advisory committee does not support AstraZeneca’s camizestrant for breast cancer - Investing.com
Astrazeneca Plc Azioni (AZN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):